ENTX vs SRZN: stock comparison and AI forecast
Entera Bio Ltd. (ENTX) and Surrozen, Inc./De (SRZN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ENTX Entera Bio Ltd.
- Price
- $3.09 +178.4% · 6M
- Market Cap
- $535M
- P/E Ratio
- 9.4x
- Size
- small-cap
- AI Forecast
SRZN Surrozen, Inc./De
- Price
- $29.02 -9.5% · 6M
- Market Cap
- $527M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ENTX and SRZN have similar market capitalizations ($535M and $527M).
- Over the last six months ENTX returned +178.4% and SRZN -9.5%.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ENTX | SRZN |
|---|---|---|
| Market Cap | $535M | $527M |
| P/E Ratio | 9.36x | – |
| P/B Ratio | 73.63x | – |
| EPS | $0.33 | $-39.55 |
| Book Value/Share | $0.04 | – |
| Revenue/Share | $0.00 | $0.66 |
| FCF/Share | $-0.06 | $-2.00 |
Profitability & Margins
| Metric | ENTX | SRZN |
|---|---|---|
| ROIC | -82.9% | -41.6% |
| Operating Margin | – | -385.3% |
| EBT Margin | – | -2122.2% |
| Tax Rate | – | 0.0% |
Financial Health
| Metric | ENTX | SRZN |
|---|---|---|
| Current Ratio | 8.98x | 12.14x |
| D/E Ratio | 1.68x | – |
| Financial Leverage | 2.68x | – |
| Interest Coverage | – | -456.8x |
| Working Capital | $17M | $100M |
Cash Flow
| Metric | ENTX | SRZN |
|---|---|---|
| Operating Cash Flow | -$11M | -$35M |
| Free Cash Flow | -$11M | -$35M |
| Capital Spending | -$70K | -$220K |
| FCF/Sales | – | -303.9% |
| CapEx/Sales | – | 1.9% |
Operational Efficiency
| Metric | ENTX | SRZN |
|---|---|---|
| Asset Turnover | 0.00x | 0.10x |
| Receivables Turnover | – | 2.3x |
| Fixed Assets Turnover | 0.0x | 25.2x |
| Days Sales Outstanding | – | 159 days |
Income Statement
| Metric | ENTX | SRZN |
|---|---|---|
| Total Revenue | $0.00M | $12M |
| Operating Income | -$14M | -$44M |
| R&D Expense | $9M | $35M |
| SG&A Expense | $550K | – |
| Cost of Goods Sold | $0.00M | – |
Dividend & Shareholder Information
| Metric | ENTX | SRZN |
|---|---|---|
| Shares Outstanding | 173M | 18M |
| EPS Growth | 32.0% | – |
ENTX vs SRZN: stock comparison and AI forecast
Which is bigger, ENTX or SRZN?
ENTX and SRZN have similar market capitalizations ($535M and $527M).
Which stock performed better over the last six months, ENTX or SRZN?
Over the last six months ENTX returned +178.4% and SRZN -9.5%.
Which one does Intratio's AI model rank higher, ENTX or SRZN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.